Greg Renza

Stock Analyst at RBC Capital

(2.32)
# 2,504
Out of 4,843 analysts
1
Total ratings
100%
Success rate
8.37%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Greg Renza

BeOne Medicines
Apr 7, 2025
Initiates: Outperform
Price Target: $312
Current: $245.58
Upside: +27.05%